GlobeImmune Inc (NASDAQ:GBIM)

7.32
Delayed Data
As of 9:47am ET
 -0.24 / -3.17%
Today’s Change
4.29
Today|||52-Week Range
15.00
-3.56%
Year-to-Date
No recent news for GlobeImmune Inc.

Today’s Trading

Previous close7.56
Today’s open7.32
Day’s range7.32 - 7.32
Volume1,134
Average volume (3 months)19,355
Market cap$43.5M
Dividend yield--
Data as of 9:47am ET, 03/02/2015

Growth & Valuation

Earnings growth (last year)+99.24%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+53.80%
P/E ratio2.8
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TROVUTrovagene Inc0.000.00%
INISInternational Isotop...0.000.00%
TRILTrillium Therapeutic...-0.01-0.07%
APPYVenaxis Inc+0.02+3.70%
Data as of 9:53am ET, 03/02/2015

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$22.5M
Annual profit (last year)$9.5M
Net profit margin42.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Timothy C. Rodell
Secretary, Treasurer &
Vice President-Finance
C. Jeffrey Dekker
Corporate headquarters
Louisville, Colorado

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account